785 related articles for article (PubMed ID: 28647765)
1. Epidemiology of hepatocellular carcinoma: target population for surveillance and diagnosis.
Tang A; Hallouch O; Chernyak V; Kamaya A; Sirlin CB
Abdom Radiol (NY); 2018 Jan; 43(1):13-25. PubMed ID: 28647765
[TBL] [Abstract][Full Text] [Related]
2. Application of surveillance programs for hepatocellular carcinoma in the Asia-Pacific Region.
Amarapurkar D; Han KH; Chan HL; Ueno Y;
J Gastroenterol Hepatol; 2009 Jun; 24(6):955-61. PubMed ID: 19383082
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology, risk factors and surveillance of hepatocellular carcinoma.
Cabibbo G; Craxì A
Eur Rev Med Pharmacol Sci; 2010 Apr; 14(4):352-5. PubMed ID: 20496547
[TBL] [Abstract][Full Text] [Related]
4. [Epidemiology, natural history, and risk factors of hepatocellular carcinoma].
Fares N; Péron JM
Rev Prat; 2013 Feb; 63(2):216-7, 220-2. PubMed ID: 23513788
[TBL] [Abstract][Full Text] [Related]
5. Prevention of hepatocellular carcinoma in the Asia-Pacific region: consensus statements.
Asia-Pacific Working Party on Prevention of Hepatocellular Carcinoma
J Gastroenterol Hepatol; 2010 Apr; 25(4):657-63. PubMed ID: 20492323
[TBL] [Abstract][Full Text] [Related]
6. Ultrasound surveillance for hepatocellular carcinoma of at-risk patients in Ramathibodi Hospital.
Prapruttam D; Suksai J; Kitiyakara T; Phongkitkarun S
J Med Assoc Thai; 2014 Nov; 97(11):1199-208. PubMed ID: 25675686
[TBL] [Abstract][Full Text] [Related]
7. Current epidemiology in hepatocellular carcinoma.
Konyn P; Ahmed A; Kim D
Expert Rev Gastroenterol Hepatol; 2021 Nov; 15(11):1295-1307. PubMed ID: 34624198
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma.
Kew MC
Pathol Biol (Paris); 2010 Aug; 58(4):273-7. PubMed ID: 20378277
[TBL] [Abstract][Full Text] [Related]
9. Screening and surveillance for hepatocellular carcinoma: perspective of a new era?
Maida M; Malizia G; Affronti A; Virdone R; Maida C; Margherita V; D'amico G
Expert Rev Anticancer Ther; 2016 Dec; 16(12):1291-1302. PubMed ID: 27730841
[TBL] [Abstract][Full Text] [Related]
10. [Hepatocellular carcinoma surveillance].
Costentin C
Presse Med; 2017 Apr; 46(4):381-385. PubMed ID: 28081946
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology and surveillance for hepatocellular carcinoma: New trends.
Singal AG; Lampertico P; Nahon P
J Hepatol; 2020 Feb; 72(2):250-261. PubMed ID: 31954490
[TBL] [Abstract][Full Text] [Related]
12. [Hepatocellular carcinoma in Korea: introduction and overview].
Park JW
Korean J Gastroenterol; 2005 Apr; 45(4):217-26. PubMed ID: 15843747
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular carcinoma, a rapidly increasing public health problem: the Tulane experience 2003-2009.
Tangutur NK; Medvedev SF; Regenstein F; Balart LA
J La State Med Soc; 2011; 163(4):185-90. PubMed ID: 21954650
[TBL] [Abstract][Full Text] [Related]
14. Noncontrast magnetic resonance imaging versus ultrasonography for hepatocellular carcinoma surveillance (MIRACLE-HCC): study protocol for a prospective randomized trial.
An C; Kim DY; Choi JY; Han KH; Roh YH; Kim MJ
BMC Cancer; 2018 Sep; 18(1):915. PubMed ID: 30249190
[TBL] [Abstract][Full Text] [Related]
15. Screening for and surveillance of high-risk patients with HBV-related chronic liver disease: promoting the early detection of hepatocellular carcinoma in China.
Song P; Feng X; Zhang K; Song T; Ma K; Kokudo N; Dong J; Yao L; Tang W
Biosci Trends; 2013 Feb; 7(1):1-6. PubMed ID: 23524887
[TBL] [Abstract][Full Text] [Related]
16. Geographic variation within the United States in the incidence of hepatocellular carcinoma.
Davila JA; Petersena NJ; Nelson HA; El-Serag HB
J Clin Epidemiol; 2003 May; 56(5):487-93. PubMed ID: 12812824
[TBL] [Abstract][Full Text] [Related]
17. Diabetes mellitus, metabolic syndrome and obesity are not significant risk factors for hepatocellular carcinoma in an HBV- and HCV-endemic area of Southern Taiwan.
Chen CT; Chen JY; Wang JH; Chang KC; Tseng PL; Kee KM; Chen PF; Tsai LS; Chen SC; Lin SC; Lu SN
Kaohsiung J Med Sci; 2013 Aug; 29(8):451-9. PubMed ID: 23906236
[TBL] [Abstract][Full Text] [Related]
18. High prevalence of multinodular hepatocellular carcinoma in patients with cirrhosis attributable to multiple risk factors.
Fasani P; Sangiovanni A; De Fazio C; Borzio M; Bruno S; Ronchi G; Del Ninno E; Colombo M
Hepatology; 1999 Jun; 29(6):1704-7. PubMed ID: 10347111
[TBL] [Abstract][Full Text] [Related]
19. Global Epidemiology, Prevention, and Management of Hepatocellular Carcinoma.
Mak LY; Cruz-Ramón V; Chinchilla-López P; Torres HA; LoConte NK; Rice JP; Foxhall LE; Sturgis EM; Merrill JK; Bailey HH; Méndez-Sánchez N; Yuen MF; Hwang JP
Am Soc Clin Oncol Educ Book; 2018 May; 38():262-279. PubMed ID: 30231359
[TBL] [Abstract][Full Text] [Related]
20. Comparison of biannual ultrasonography and annual non-contrast liver magnetic resonance imaging as surveillance tools for hepatocellular carcinoma in patients with liver cirrhosis (MAGNUS-HCC): a study protocol.
Kim HA; Kim KA; Choi JI; Lee JM; Lee CH; Kang TW; Ku YM; Lee SL; Park YS; Yoon JH; Kim SH; Choi MH
BMC Cancer; 2017 Dec; 17(1):877. PubMed ID: 29268722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]